Diabetes has been declared a global epidemic, the rapid increase in the number of people living with diabetes worldwide underscores the need for more effective treatments that can delay and even prevent the use of insulin injections. Researchers have been working for decades to try to develop an oral form of insulin that can be released through the digestive system, mimicking the natural production of insulin in the body. A company has made a scientific breakthrough in the oral administration of proteins and is on track to be the first company to market an oral insulin capsule. Oramed Pharmaceuticals will soon enter phase III trials for its oral insulin capsule and the company's CEO, Nadav Kidron, joins remotely to discuss the revolutionary discovery and its implications in the treatment of diabetes.
Video credits to CorporateProfile YouTube channel